CANTAM CANTAM DOCS UNION EUROPEENNE





Professor Joseph KAMGNO, member of the CANTAM network, winner of the 2022 Christophe MERIEUX prize

Published in 03/06/2022 Written by Espoir Vawou

The Central African Clinical Research Network (Le Réseau de Recherche Clinique d'Afrique Centrale) – CANTAM (cantam.org) coordinated by the Congolese Foundation for Medical Research (la Fondation Congolaise pour la Recherche Médicale) is delighted to announce that the 2022 Christophe Mérieux Prize has been won by Professor Joseph KAMGNO, a member of this prestigious CANTAM network.

With a worth of 500,000 Euros, the « Christophe Mérieux Prize » is each year awarded to a researcher or a research team specialized in the studies of infectious diseases in developing countries. So, this year 2022, the prize has been awarded to an epidemiologist and lecturer at the Faculty of Medicine in the University of Yaoundé-I - Professor Joseph KAMGNO, for his study on the fight against onchocerciasis.

CANTAM network therefore sincerely congratulates Professor Joseph KAMGNO, who is a relentless scientist with many responsibilities in health, higher education and research institutes in Cameroon, particular the position of Director at the Center for Research on Filariasis and other diseases (Centre de Recherches sur les filarioses et autres maladies tropicales) (CRFiLMT). Professor KAMGNO is highly involved in capacity building for the research on neglected tropical diseases, and equally conducts clinical trials thereby contributing to the training of many other personnel in the Central African sub-region.

Worthy of note is the fact that, Professor Joseph KAMGNO as a member of the CANTAM Network of excellence, comes second to Professor Francine NTOUMI who won this same prize in 2016.


Leave a comment

Make sure you enter all the required information, indicated by an asterisk ( * ). HTML code is not allowed.







Subscribe For Newsletter

Subscribe to our newsletter to receive the latest news on our activities


Let’s fight HIV/AIDS, Malaria, Tuberculosis and NTDs